06/11/2021
7:36 AM | Bellerophon Therapeutics (Filer)
| Form 8-K/A
| |
06/11/2021
7:31 AM | Bellerophon Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/08/2021
11:37 AM | Bellerophon Therapeutics (Issuer)
Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Life Science Opportunities Fund VI (Reporting)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2021
3:05 PM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2021
7:36 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2021
7:30 AM | Bellerophon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/27/2021
8:45 PM | Bellerophon Therapeutics (Subject)
Puissance Life Science Opportunities Fund VI (Filed by)
| Form SC 13D/A
| |
04/26/2021
11:39 AM | Bellerophon Therapeutics (Issuer)
Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Life Science Opportunities Fund VI (Reporting)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/13/2021
7:36 AM | Bellerophon Therapeutics (Filer)
| Form DEFA14A
| |
04/13/2021
7:31 AM | Bellerophon Therapeutics (Filer)
| Form DEF 14A
| |
|
04/02/2021
3:10 PM | Bellerophon Therapeutics (Issuer)
Peacock Jonathan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2021
8:36 PM | Bellerophon Therapeutics (Issuer)
KLINSKY STEVEN B (Reporting)
New Mountain Capital, L.L.C. (Reporting)
New Mountain Investments II, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2021
7:35 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2021
7:31 AM | Bellerophon Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2021
4:27 PM | Bellerophon Therapeutics (Subject)
New Mountain Investments II, LLC (Filed by)
| Form SC 13G/A
| |
01/11/2021
7:01 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2021
12:52 PM | Bellerophon Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
12/01/2020
7:31 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/23/2020
7:33 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2020
7:30 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2020
7:29 AM | Bellerophon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/14/2020
3:04 PM | Bellerophon Therapeutics (Issuer)
FARES Wassim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2020
3:04 PM | Bellerophon Therapeutics (Issuer)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2020
3:03 PM | Bellerophon Therapeutics (Issuer)
Teufel Crispin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2020
3:03 PM | Bellerophon Therapeutics (Issuer)
Moura Andre V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2020
3:03 PM | Bellerophon Therapeutics (Issuer)
BENNETT MATTHEW (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2020
3:02 PM | Bellerophon Therapeutics (Issuer)
Cloyd Mary Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2020
3:02 PM | Bellerophon Therapeutics (Issuer)
Bruder Scott P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2020
3:02 PM | Amin Naseem (Reporting)
Bellerophon Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2020
7:31 AM | Bellerophon Therapeutics (Issuer)
FARES Wassim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2020
3:10 PM | Bellerophon Therapeutics (Issuer)
FARES Wassim (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/05/2020
7:31 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2020
7:26 AM | Bellerophon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/13/2020
7:33 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2020
11:15 PM | Bellerophon Therapeutics (Filer)
| Form EFFECT
| |
06/26/2020
3:07 PM | Bellerophon Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/22/2020
6:38 AM | Bellerophon Therapeutics (Subject)
Puissance Life Science Opportunities Fund VI (Filed by)
| Form SC 13D
| |
05/22/2020
6:25 AM | Bellerophon Therapeutics (Issuer)
Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Life Science Opportunities Fund VI (Reporting)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2020
5:46 AM | Bellerophon Therapeutics (Subject)
Puissance Cross-Border Opportunities III LLC (Filed by)
| Form SC 13D/A
| |
05/11/2020
3:01 PM | Bellerophon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2020
7:29 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/27/2020
3:31 PM | Bellerophon Therapeutics (Filer)
| Form DEFA14A
| |
04/23/2020
7:17 AM | Bellerophon Therapeutics (Filer)
| Form DEF 14A
| |
04/20/2020
9:47 AM | Bellerophon Therapeutics (Issuer)
Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Cross-Border Opportunities III LLC (Reporting)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2020
7:31 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/06/2020
7:32 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/06/2020
7:27 AM | Bellerophon Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2020
12:28 PM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2020
6:03 AM | Bellerophon Therapeutics (Filer)
| Form 424B5
| |
03/30/2020
9:49 AM | Bellerophon Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G
| |
03/30/2020
7:01 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2020
7:33 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2020
7:33 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2020
7:32 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2020
9:00 AM | Bellerophon Therapeutics (Subject)
New Mountain Investments II, LLC (Filed by)
| Form SC 13G/A
| |
02/07/2020
11:05 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2020
3:24 PM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2020
3:51 PM | Bellerophon Therapeutics (Issuer)
Peacock Jonathan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2020
7:22 AM | Bellerophon Therapeutics (Filer)
| Form DEF 14A
| |
12/27/2019
7:25 AM | Bellerophon Therapeutics (Filer)
| Form PRE 14A
| |
12/17/2019
7:24 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2019
3:52 PM | Bellerophon Therapeutics (Issuer)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2019
3:36 PM | Bellerophon Therapeutics (Issuer)
Shah Parag Suresh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2019
3:36 PM | Bellerophon Therapeutics (Issuer)
Fernandes Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2019
3:36 PM | Bellerophon Therapeutics (Issuer)
Tenenbaum Fabian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2019
3:35 PM | Bellerophon Therapeutics (Issuer)
Dekker Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2019
3:35 PM | Bellerophon Therapeutics (Issuer)
Korner Assaf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2019
7:31 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2019
7:31 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2019
7:31 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2019
7:30 AM | Bellerophon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2019
4:17 PM | Bellerophon Therapeutics (Issuer)
Shah Nimish P (Reporting)
VENROCK ASSOCIATES IV L P (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2019
4:15 PM | Bellerophon Therapeutics (Issuer)
Koh Bong Y (Reporting)
VEF Management IV, LLC (Reporting)
VENROCK ASSOCIATES IV L P (Reporting)
VENROCK ENTREPRENEURS FUND IV L P (Reporting)
Venrock Healthcare Capital Partners II, L.P. (Reporting)
Venrock Management IV, LLC (Reporting)
Venrock Partners Management, LLC (Reporting)
Venrock Partners, L.P. (Reporting)
VHCP Co-Investment Holdings II, LLC (Reporting)
VHCP Management II, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2019
7:31 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2019
3:54 PM | Bellerophon Therapeutics (Issuer)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2019
3:54 PM | Bellerophon Therapeutics (Issuer)
Teufel Crispin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2019
3:53 PM | Bellerophon Therapeutics (Issuer)
Shah Parag Suresh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2019
3:53 PM | Bellerophon Therapeutics (Issuer)
Moura Andre V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2019
3:53 PM | Bellerophon Therapeutics (Issuer)
Fernandes Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2019
3:52 PM | Bellerophon Therapeutics (Issuer)
Tenenbaum Fabian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2019
3:52 PM | Bellerophon Therapeutics (Issuer)
Dekker Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2019
3:51 PM | Bellerophon Therapeutics (Issuer)
Cloyd Mary Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2019
3:51 PM | Bellerophon Therapeutics (Issuer)
Bruder Scott P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2019
3:50 PM | Bellerophon Therapeutics (Issuer)
Korner Assaf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2019
3:50 PM | Amin Naseem (Reporting)
Bellerophon Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2019
3:48 PM | Bellerophon Therapeutics (Issuer)
BENNETT MATTHEW (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2019
3:39 PM | Bellerophon Therapeutics (Issuer)
Edmonds Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2019
7:31 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2019
12:08 PM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2019
7:32 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2019
7:31 AM | Bellerophon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2019
7:35 AM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2019
3:31 PM | Bellerophon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2019
10:46 AM | Bellerophon Therapeutics (Issuer)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:46 PM | Bellerophon Therapeutics (Issuer)
Teufel Crispin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
7:24 AM | Bellerophon Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/24/2019
8:30 AM | Bellerophon Therapeutics (Issuer)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2019
3:46 PM | Bellerophon Therapeutics (Issuer)
Edmonds Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
10:15 AM | Bellerophon Therapeutics (Issuer)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
10:14 AM | Bellerophon Therapeutics (Issuer)
Peacock Jonathan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
